UBS downgrades the rating of Sonova
The financial institution sees a risk of increased competition and is concerned about a high valuation.
AF MARKETWIRE
The world’s largest hearing aid maker, Sonova, received a downgrade from UBS on Friday, which sees a risk of increased competition and is concerned about the high valuation.
Sonova was downgraded from ”neutral” to ”sell”.
UBS expects Sonova’s earnings momentum to slow slightly in the short term, although the company is ”a quality company in a market that is growing at a sustainable 4-5%”.
